Eradication of Metastatic Renal Cell Carcinoma after Adenovirus-Encoded TNF-Related Apoptosis-Inducing Ligand (TRAIL)/CpG Immunotherapy

Oxidative Stress Regulates Expression of VEGFR1 in Myeloid Cells: Link to Tumor-Induced Immune Suppression in Renal Cell Carcinoma

(2014) S. Kusmartsev et al.   JOURNAL OF IMMUNOLOGY

Immunotherapy of metastatic renal cell carcinoma

(2010) David F. McDermott   CANCER

Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer

(2010) P J Wysocki et al.   CANCER GENE THERAPY

Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice

(2010) Flávia Gomes de Góes Rocha et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Multiple Antitumor Mechanisms Downstream of Prophylactic Regulatory T-Cell Depletion

(2010) Michele W.L. Teng et al.   CANCER RESEARCH

Direct and Differential Suppression of Myeloid-Derived Suppressor Cell Subsets by Sunitinib Is Compartmentally Constrained

(2010) Jennifer S. Ko et al.   CANCER RESEARCH

New Strategies in Kidney Cancer: Therapeutic Advances through Understanding the Molecular Basis of Response and Resistance

(2010) B. I. Rini   CLINICAL CANCER RESEARCH

TRAIL receptor signaling and therapeutics

(2010) Junaid Abdulghani et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Langerhans cells: critical regulators of skin immunity?

(2010) Björn E Clausen et al.   IMMUNOLOGY AND CELL BIOLOGY

Clearance of apoptotic cells: implications in health and disease

(2010) Michael R. Elliott et al.   JOURNAL OF CELL BIOLOGY

Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

(2010) Sergio A. Quezada et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice

(2010) Jennifer A Westwood et al.   Journal of Translational Medicine

Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients

(2009) Sujata Patil et al.   CANCER

Antigen Presented by Tumors In vivo Determines the Nature of CD8+ T-Cell Cytotoxicity

(2009) A. Shanker et al.   CANCER RESEARCH

Tumor-Infiltrating Regulatory Dendritic Cells Inhibit CD8+ T Cell Function via L-Arginine Metabolism

(2009) L. A. Norian et al.   CANCER RESEARCH

Sunitinib Inhibition of Stat3 Induces Renal Cell Carcinoma Tumor Cell Apoptosis and Reduces Immunosuppressive Cells

(2009) H. Xin et al.   CANCER RESEARCH

T Cell-Based Immunotherapy of Metastatic Renal Cell Carcinoma: Modest Success and Future Perspective

(2009) A. Shablak et al.   CLINICAL CANCER RESEARCH

Immunotherapy for Human Renal Cell Carcinoma by Adoptive Transfer of Autologous Transforming Growth Factor  -Insensitive CD8+ T Cells

(2009) L. Wang et al.   CLINICAL CANCER RESEARCH

TRAIL Gene Therapy: From Preclinical Development to Clinical Application

(2009) Thomas Griffith et al.   CURRENT GENE THERAPY

TNF-related apoptosis-inducing ligand (TRAIL): A new path to anti-cancer therapies

(2009) Peter A. Holoch et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Immunological Response to Renal Cryoablation in an In Vivo Orthotopic Renal Cell Carcinoma Murine Model

(2009) Surena F. Matin et al.   JOURNAL OF UROLOGY

Phase 1 Evaluation of Intralesionally Injected TLR9-agonist PF-3512676 in Patients With Basal Cell Carcinoma or Metastatic Melanoma

(2008) Maja A. Hofmann et al.   JOURNAL OF IMMUNOTHERAPY

Treating Metastatic Solid Tumors With Bortezomib and a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Agonist Antibody

(2008) A. Shanker et al.   JNCI-Journal of the National Cancer Institute

An Anti-Double-Stranded DNA Monoclonal Antibody Induced by Tumor Cell–Derived DNA Inhibits the Growth of Tumor In Vitro and In Vivo via Triggering Apoptosis

(2007) Qinghua Cao et al.   DNA AND CELL BIOLOGY